Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis

Published:2022-01 Issue:1 Volume:12 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical & Translational All

Author:

Zhang Yuan¹²³^ORCID,Xi Lin¹²³,Gao Yunbo⁴,Huang Yanran⁴^ORCID,Cao Feifei¹,Xiong Wei¹,Wang Chengshuo¹²³⁴,Zhang Luo¹²³⁴^ORCID

Affiliation:

1. Department of Allergy Beijing TongRen Hospital Capital Medical University Beijing China

2. Beijing Key Laboratory of Nasal Diseases Beijing Institute of Otolaryngology Beijing China

3. Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases Chinese Academy of Medical Sciences Beijing China

4. Department of Otolaryngology Head and Neck Surgery Beijing TongRen Hospital Capital Medical University Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clt2.12094

Reference31 articles.

1. Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China

2. Comparative analysis of chronic rhinitis patient profiles during autumn pollen season between grassland and non-grassland cities in North China

3. Prevalence of pollen‐induced allergic rhinitis with high pollen exposure in grasslands of northern China

4. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Main Airborne Pollen Species and Characteristics of Allergic Rhinitis Patients with Pollen-Related Allergies in 13 Northern Chinese Cities;Journal of Asthma and Allergy;2024-08

2. Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial;Frontiers in Immunology;2024-07-29

3. Endotyping Chronic Respiratory Diseases: T2 Inflammation in the United Airways Model;Life;2024-07-19

4. Blood and local eosinophil levels in chronic rhinitis: Observations during seasonal allergen exposure and non-exposure;World Allergy Organization Journal;2024-07

5. Les phénotypes patients : regards du dermatologue et allergologue sur le traitement des patients atteints de DA selon leur profil atopique;Annales de Dermatologie et de Vénéréologie - FMC;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3